2009-11-10 03:15:01 -
Celsion Corporation - Pharmaceuticals & Healthcare - Deals and Alliances Profile - a new market research report on companiesandmarkets.com www.companiesandmarkets.com/Summary-Company-Profile/celsion-corp ..
Celsion Corporation - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Summary
Celsion Corporation (Celsion) is a biotechnology company engaged in the development and marketing of drugs to treat cancer and other diseases. Its flagship product ThermoDox is currently undergoing Phase III clinical trial for primary liver cancer and a Phase II study for recurrent chest wall breast cancer (RCW). It is
also developing numerous products that employ its heat activated liposomal technology. In December 2008, the company entered into an agreement with Yakult Honsha for the commercialization of its proprietary ThermoDox drug delivery platform for the Japanese market.
The Celsion Corporation - Pharmaceuticals & Healthcare - Deals and Alliances Profile is an essential source for company data and information. The profile examines the companys key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy as well as highlighting the companys major recent financial deals.
Scope
- Provides key company information for business intelligence needs
- Gives information on the companys major recent financial deals including Mergers and Acquisitions, asset transactions, PE/VC deals, equity offerings, debt offerings and partnerships.
- Data is supplemented with details on the companys history, key executives, business description, locations and subsidiaries as well as a list of products and services and the latest available company statement.
Reasons to buy
- A quick ""one-stop-shop"" to understand the company.
- Support sales activities by understanding your customers businesses.
- Qualify prospective partners and suppliers.
- Understand and respond to your competitors business structure, strategy and prospects through.
- Understanding the key deals which have shaped the company.
